Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Short-term Investments: 2010-2023

Historic Short-term Investments for Ironwood Pharmaceuticals (IRWD) over the last 13 years, with Sep 2023 value amounting to $788,000.

  • Ironwood Pharmaceuticals' Short-term Investments fell 36.96% to $788,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $788,000, marking a year-over-year decrease of 36.96%. This contributed to the annual value of $1.3 million for FY2022, which is negligibly% changed negligibly from last year.
  • Ironwood Pharmaceuticals' Short-term Investments amounted to $788,000 in Q3 2023, which was down 0.00% from $788,000 recorded in Q2 2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Short-term Investments ranged from a high of $11.3 million in Q2 2021 and a low of $788,000 during Q2 2023.
  • Its 3-year average for Short-term Investments is $2.7 million, with a median of $1.3 million in 2022.
  • In the last 5 years, Ironwood Pharmaceuticals' Short-term Investments crashed by 97.48% in 2019 and then soared by 800.96% in 2021.
  • Over the past 5 years, Ironwood Pharmaceuticals' Short-term Investments (Quarterly) stood at $1.2 million in 2019, then skyrocketed by 38.80% to $1.7 million in 2020, then declined by 25.07% to $1.3 million in 2021, then remained steady at $1.3 million in 2022, then plummeted by 36.96% to $788,000 in 2023.
  • Its Short-term Investments stands at $788,000 for Q3 2023, versus $788,000 for Q2 2023 and $1.2 million for Q1 2023.